[Federal Register Volume 88, Number 12 (Thursday, January 19, 2023)]
[Notices]
[Page 3428]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-00911]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Prevention's (CSAP) Drug Testing Advisory 
Board (DTAB) will convene via web conference on March 7, 2023, from 10 
a.m. EST to 4:30 p.m. EST.
    The board will meet in open-session March 7, 2023, from 10 a.m. EST 
to 2 p.m. EST to discuss the Mandatory Guidelines for Federal Workplace 
Drug Testing Programs, updates to the Electronic Chain of Custody Form 
(ECCF), as well as updates from the Department of Transportation, the 
Nuclear Regulatory Commission, the Department of Defense, and the Food 
and Drug Administration as well as a presentation by Dr. Svante 
Vikingsson on Fentanyl and Opioids Pulse Study results.
    The board will meet in closed session on March 7, 2023, from 2:15 
p.m. EST to 4:30 p.m. EST to discuss issues surrounding cannabinoids 
pertaining to the effect of the proliferation of various cannabinoid 
isomers, including Delta-8-THC, on federal workplace drug testing 
programs, including federal and state responses to cannabinoid drug 
testing issues of concern, and potential SAMSHA actions. In closed 
session the board will also review information and proposed actions 
concerning the Department of Health and Humans Services (HHS) Mandatory 
Guideline internal review and approval process that has not been made 
public by HHS. Therefore, the March 7, 2023, meeting from 2:15 p.m. to 
4:30 p.m. is closed to the public, as determined by the Assistant 
Secretary for Mental Health and Substance Use, SAMHSA, in accordance 
with 5 U.S.C. 552b(c)(9)(B) and 5 U.S.C. App. 2, section 10(d).
    Meeting registration information can be completed at https://snacregister.samhsa.gov/. Web conference and call information will be 
sent after completing registration. Meeting information and a roster of 
DTAB members may be obtained by accessing the SAMHSA Advisory 
Committees website, https://www.samhsa.gov/about-us/advisory-councils/meetings, or by contacting the Designated Federal Officer, Lisa Davis.
    Committee Name: Substance Abuse and Mental Health Services 
Administration, Center for Substance Abuse Prevention, Drug Testing 
Advisory Board.
    Dates/Time/Type: March 7, 2023, from 10 a.m. EST to 2 p.m. EST: 
OPEN; March 7, 2023, from 2:15 p.m. EST to 4:30 p.m. EST: CLOSED.
    Place: Substance Abuse and Mental Health Services Administration, 
5600 Fishers Lane, Rockville, MD 20857.
    Contact: Lisa S. Davis, M.S., Social Science Analyst, Center for 
Substance Abuse Prevention, 5600 Fishers Lane, Rockville, Maryland 
20857, Telephone: (240) 276-1440, Email: [email protected].

Anastasia Marie Donovan,
Public Health Advisor, Division of Workplace Programs.
[FR Doc. 2023-00911 Filed 1-18-23; 8:45 am]
BILLING CODE 4162-20-P